Edwards Lifesciences Price to Sales Ratio 2010-2022 | EW
Historical PS ratio values for Edwards Lifesciences (EW) over the last 10 years. The current P/S ratio for Edwards Lifesciences as of January 27, 2023 is .
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
| Edwards Lifesciences P/S Ratio Historical Data |
| Date |
Stock Price |
TTM Sales per Share |
Price to Sales Ratio |
| 2023-01-27 |
78.14 |
|
9.15 |
| 2022-09-30 |
82.63 |
$8.54 |
9.67 |
| 2022-06-30 |
95.09 |
$8.50 |
11.18 |
| 2022-03-31 |
117.72 |
$8.50 |
13.86 |
| 2021-12-31 |
129.55 |
$8.29 |
15.62 |
| 2021-09-30 |
113.21 |
$8.07 |
14.03 |
| 2021-06-30 |
103.57 |
$7.81 |
13.27 |
| 2021-03-31 |
83.64 |
$7.11 |
11.76 |
| 2020-12-31 |
91.23 |
$6.96 |
13.10 |
| 2020-09-30 |
79.82 |
$6.92 |
11.53 |
| 2020-06-30 |
69.11 |
$6.83 |
10.12 |
| 2020-03-31 |
62.87 |
$7.05 |
8.92 |
| 2019-12-31 |
77.76 |
$6.83 |
11.38 |
| 2019-09-30 |
73.30 |
$6.51 |
11.25 |
| 2019-06-30 |
61.58 |
$6.21 |
9.91 |
| 2019-03-31 |
63.78 |
$5.97 |
10.68 |
| 2018-12-31 |
51.06 |
$5.78 |
8.83 |
| 2018-09-30 |
58.03 |
$5.53 |
10.50 |
| 2018-06-30 |
48.52 |
$5.41 |
8.97 |
| 2017-12-31 |
37.57 |
$5.30 |
7.09 |
| 2017-09-30 |
36.44 |
$5.10 |
7.14 |
| 2017-06-30 |
39.41 |
$5.22 |
7.55 |
| 2017-03-31 |
31.36 |
$5.05 |
6.21 |
| 2016-12-31 |
31.23 |
$4.86 |
6.43 |
| 2018-03-31 |
46.51 |
$4.75 |
9.79 |
| 2016-09-30 |
40.19 |
$4.38 |
9.18 |
| 2016-06-30 |
33.24 |
$4.18 |
7.95 |
| 2016-03-31 |
29.40 |
$3.95 |
7.44 |
| 2015-12-31 |
26.33 |
$3.78 |
6.97 |
| 2015-09-30 |
23.70 |
$3.71 |
6.39 |
| 2015-06-30 |
23.74 |
$3.71 |
6.40 |
| 2015-03-31 |
23.74 |
$3.67 |
6.47 |
| 2014-12-31 |
21.23 |
$3.58 |
5.93 |
| 2014-09-30 |
17.03 |
$3.41 |
4.99 |
| 2014-06-30 |
14.31 |
$3.21 |
4.45 |
| 2014-03-31 |
12.36 |
$3.07 |
4.03 |
| 2013-12-31 |
10.96 |
$2.98 |
3.68 |
| 2013-09-30 |
11.61 |
$2.91 |
3.98 |
| 2013-06-30 |
11.20 |
$2.81 |
3.99 |
| 2013-03-31 |
13.69 |
$2.74 |
5.01 |
| 2012-12-31 |
15.03 |
$2.67 |
5.62 |
| 2012-09-30 |
17.90 |
$2.55 |
7.00 |
| 2012-06-30 |
17.22 |
$2.51 |
6.87 |
| 2012-03-31 |
12.12 |
$2.43 |
5.00 |
| 2011-12-31 |
11.78 |
$2.33 |
5.07 |
| 2011-09-30 |
11.88 |
$2.21 |
5.36 |
| 2011-06-30 |
14.53 |
$2.15 |
6.76 |
| 2010-12-31 |
13.47 |
$2.03 |
6.65 |
| 2010-09-30 |
11.18 |
$1.97 |
5.67 |
| 2010-06-30 |
9.34 |
$2.04 |
4.58 |
| 2010-03-31 |
8.24 |
$1.99 |
4.14 |
| 2009-12-31 |
7.24 |
$1.99 |
3.63 |
| 2011-03-31 |
14.50 |
$1.95 |
7.45 |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical Instruments Manufacturing |
$48.354B |
$5.233B |
|
Edwards Lifesciences Corporation deals in products and technologies aimed at treating advanced cardiovascular diseases, especially structural heart disease in critically ill patients. The company is the world's leading manufacturer of tissue heart valves and repair products used to replace or repair a patient's diseased or defective heart valve. Edwards is also a leading player in hemodynamic monitoring systems used to measure a patient's cardiovascular function in the hospital setting. The company's products and technologies are categorized into four main areas: Transcatheter Aortic Valve Replacement (TAVR), Transcatheter Mitral and Tricuspid Therapies (TMTT), Surgical Structural Heart, and Critical Care.
|
